It’s notable that inhibition of tumor-derived (human) MMP9 alone was not as effective in metastases reduction as dual targeting of both tumor and stromal MMP9 (see Fig 7G and 7H), while inhibition of stroma-derived MMP9 (mouse) was as effective as dual targeting (see Fig 7G). The gene discussed is MMP9; the disease is neoplasm.